22
Participants
Start Date
May 31, 2008
Primary Completion Date
March 31, 2010
Study Completion Date
December 31, 2011
paclitaxel
Paclitaxel will be administered IV over 3 hours on Day 1 every 21 days.
carboplatin
Carboplatin will be administered intravenously (IV) over 30 minutes on day 1 after pacitaxel administration, every 21 days.
BSI-201 (Iniparib)
BSI-201 will be administered IV over one hour twice weekly beginning on day 1 (doses of BSI-201 must be separated by at least 2 days).
Research Site, Richmond
Research Site, Roanoke
Research Site, Winston-Salem
Research Site, Charlotte
Research Site, Orlando
Research Site, Columbus
Research Site, Indianapolis
Research Site, Madison
Research Site, Chicago
Research Site, St Louis
Research Site, Springfield
Research Site, Baton Rouge
Research Site, Oklahoma City
Research Site, Aurora
Research Site, Englewood
Research Site, New Britain
Research Site, Gainsville
Research Site, Savannah
Research Site, Chicago
Research Site, Hinsdale
Research Site, Urbana
Research Site, Scarborough
Research Site, Kalamazoo
Research Site, Brooklyn
Research Site, Buffalo
Research Site, New York
Research Site, Stony Brook
Research Site, Chapel Hill
Research Site, Charlotte
Research Site, Cleveland
Research Site, Columbus
Research Site, Mentor
Research Site, Tulsa
Research Site, Abington
Research Site, Pittsburgh
Research Site, Wynnewood
Research Site, Wyomissing
Research Site, Camden
Research Site, Providence
Research Site, Burlington
Lead Sponsor
Gynecologic Oncology Group
NETWORK
Sanofi
INDUSTRY